Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

794.96 +6.76 (+0.86%)
Streaming Delayed Price Updated: 10:23 AM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
99 100 Next >
'Not Just A Weight Loss Story:' Eli Lilly CEO Thinks It's Possible To Meet BofA's $60B Revenue Projection From New Drug Launches
Ricks highlighted that the company is trying to prove the efficacy of its drugs for not only weight loss but also obesity-driven diseases such as heart risks, diabetes, and sleep apnea. 
Via Benzinga
The Penny Stock Prophecy: 3 Overlooked Stocks Primed to Pop
Overlooked penny stocks are the path to outsized gains and these shares seem to fit the bill at the moment. 
Via InvestorPlace
10 Best Vanguard Funds to Buy Right Now
These 10 Vanguard stock ETFs can help you build a top-notch portfolio. 
Via The Motley Fool
Topics ETFs
Chinese Scientists Achieve World's First Diabetes Cure Using Cell Therapy: Report
A team of Chinese scientists has successfully cured a patient's diabetes using cell therapy, marking a global first. 
Via Benzinga
Surprise: Eli Lilly Is Racing Toward Yet Another Blockbuster
This winner can't stop winning. 
Via The Motley Fool
Got $500? 3 Pharma Stocks to Buy and Hold Forever
These players might even beat the market when the conditions are right. 
Via The Motley Fool
Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
The gold rush for obesity medications just got a bit more intense. 
Via The Motley Fool
3 High-Flying Stocks That Could Soar Even More
The momentum should continue for Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals. 
Via The Motley Fool
Elon Musk Says Ozempic 'Will Become Very Cheap' After New Comedy Special Paints It As Weight Loss Drug Only Wealthy People Can Afford
Elon Musk predicts that Novo Nordisk's weight-loss drug Ozempic will eventually become very cheap, following its depiction in a new South Park special as a luxury medication accessible only to the... 
Via Benzinga
Eli Lilly Makes Largest Manufacturing Investment In Its History To Boost Production For Antidiabetic And Weight Loss Meds
Eli Lilly has significantly increased its investment in its Lebanon, Indiana, manufacturing site to $9 billion, aiming to enhance production of tirzepatide injections. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Stock Market Hits A Wall Despite Booming Nvidia: Weekly Review
The Nasdaq and S&P 500 hit record highs, but fell back. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Jim Cramer Says This Basic Materials Stock Is 'Too Dicey,' Shares His Take On Arista Networks
"All of these stocks are a little volatile right now, but I think you want to own it and buy it into the volatility," Jim Cramer says. 
Via Benzinga
Stocks to Buy: 7 Undeniable Dow Darlings to Pile Into Now
Most Dow stocks are strong investments but these 7 stand out at the moment as the macroenvironment trends positive again. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
7 Stocks to Buy if the Market Ends Up Plunging
If the bears finally catch up to the bulls and take them down, these are the proven stocks to buy if the market falls. 
Via InvestorPlace
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next
Weight loss drugs get the new parody treatment in a "South Park" streaming special. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Bonds Break Down And Send Everyone To Cash
This situation is where the danger, the opportunity, and the action are right now. 
Via Talk Markets
3 Biotech Stocks to Buy on the Dip: May 2024
These biotech giants offer investors the best opportunity money can buy for excellent profits and returns this year. 
Via InvestorPlace
8 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study
Via CannabisNewsWire
Topics Intellectual Property
Exposures Intellectual Property
3 Blue Chip Stocks That You Can Buy and Hold for Years
You won't be taking on much risk by investing in these stalwarts. 
Via The Motley Fool
Move Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon.
The search for the next GLP-1 drugs that will be blockbuster winners during the next market cycle is on, and here are three contenders. 
Via InvestorPlace
Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns
Compounding weight loss drugs, which are similar to brand-name medications such as Ozempic and Mounjaro, will be banned in Australia. 
Via Benzinga
The 500 Top Stocks to Buy in May, According to AI
MarketMaster AI tells us that the top stocks to buy in May represent high-quality companies with strong fundamentals. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Retire Rich: 3 Game-Changing Stocks to Own for the Next 10 Years
Here are three game-changing retirement stocks to own for the long-term, for those looking to create meaningful long-term wealth. 
Via InvestorPlace
Topics Retirement
Exposures Pension
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
The Structure Therapeutics stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the stock a significant upside potential. 
Via Benzinga
Tesla's Fall From Grace: Down 55% From Its Peak
There was a time when Tesla was the Nvidia of its day. Its stock did nothing but go up, and its earnings calls were intensely anticipated. For a full 30 months now, Tesla is down 55% from its peak. 
Via Talk Markets
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
Roundhill CEO Dave Mazza says investors "can't just buy a basket of big pharma names or a broad-based biotech ETF and call it a day." 
Via Benzinga
Topics ETFs
3 Growth Stocks That Could Be Millionaire-Makers: May Edition
Investors wanting to get rich should consider a long-term holding in these stocks, each of which has risen exponentially in the last year. 
Via InvestorPlace
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.